stella
beta
Clinical and Biomarker Effects of Depot Medroxyprogesterone Acetate in Females With Sickle Cell Disease — Stella
Recruiting
Back to Sickle Cell Disease (SCD) trials
Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations
(2 sites)
United States
Emory University, Atlanta, Georgia
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
View full record on ClinicalTrials.gov